Cargando…
Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)
The Diabetes Control and Complications Trial (DCCT, 1983–1993) showed that intensive therapy (mean HbA(1c) 7.2%) compared with conventional therapy (mean HbA(1c) 9.0%) markedly reduced the risks of retinopathy, nephropathy, and neuropathy, and these reductions in complications were entirely attribut...
Autores principales: | Lachin, John M., Nathan, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929187/ https://www.ncbi.nlm.nih.gov/pubmed/34548284 http://dx.doi.org/10.2337/dc20-3097 |
Ejemplares similares
-
The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes
por: Lachin, John M., et al.
Publicado: (2021) -
Historical HbA(1c) Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88
por: Lind, Marcus, et al.
Publicado: (2021) -
Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study
por: Bebu, Ionut, et al.
Publicado: (2019) -
Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
por: Polak, Joseph F., et al.
Publicado: (2011) -
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
por: Monnier, Vincent M, et al.
Publicado: (2022)